Correlation Between Scisparc and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both Scisparc and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scisparc and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scisparc and Regen BioPharma, you can compare the effects of market volatilities on Scisparc and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scisparc with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scisparc and Regen BioPharma.
Diversification Opportunities for Scisparc and Regen BioPharma
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Scisparc and Regen is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Scisparc and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Scisparc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scisparc are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Scisparc i.e., Scisparc and Regen BioPharma go up and down completely randomly.
Pair Corralation between Scisparc and Regen BioPharma
Given the investment horizon of 90 days Scisparc is expected to under-perform the Regen BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Scisparc is 1.76 times less risky than Regen BioPharma. The stock trades about -0.04 of its potential returns per unit of risk. The Regen BioPharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 98.00 in Regen BioPharma on September 2, 2024 and sell it today you would lose (92.49) from holding Regen BioPharma or give up 94.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.73% |
| Values | Daily Returns |
Scisparc vs. Regen BioPharma
Performance |
| Timeline |
| Scisparc |
| Regen BioPharma |
Scisparc and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scisparc and Regen BioPharma
The main advantage of trading using opposite Scisparc and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scisparc position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| Scisparc vs. Virax Biolabs Group | Scisparc vs. ZyVersa Therapeutics | Scisparc vs. Unicycive Therapeutics | Scisparc vs. Quoin Pharmaceuticals Ltd |
| Regen BioPharma vs. Oncology Pharma | Regen BioPharma vs. Creative Medical Technology | Regen BioPharma vs. Therasense | Regen BioPharma vs. Enzolytics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |